These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 21547701)

  • 1. Significant attenuation of macrovascular involvement by bosentan in a patient with diffuse cutaneous systemic sclerosis with multiple digital ulcers and gangrene.
    Ichimura Y; Asano Y; Hatano M; Tamaki Z; Takekoshi T; Kogure A; Tomita M; Kawashima T; Miyazaki M; Taniguchi T; Takahashi T; Mitsui H; Sugaya M; Yao A; Kinugawa K; Sato S
    Mod Rheumatol; 2011 Oct; 21(5):548-52. PubMed ID: 21547701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bosentan for digital ulcers in patients with systemic sclerosis.
    Nagai Y; Hasegawa M; Hattori T; Okada E; Tago O; Ishikawa O
    J Dermatol; 2012 Jan; 39(1):48-51. PubMed ID: 21955007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Digital ulcers in systemic sclerosis: prevention by treatment with bosentan, an oral endothelin receptor antagonist.
    Korn JH; Mayes M; Matucci Cerinic M; Rainisio M; Pope J; Hachulla E; Rich E; Carpentier P; Molitor J; Seibold JR; Hsu V; Guillevin L; Chatterjee S; Peter HH; Coppock J; Herrick A; Merkel PA; Simms R; Denton CP; Furst D; Nguyen N; Gaitonde M; Black C
    Arthritis Rheum; 2004 Dec; 50(12):3985-93. PubMed ID: 15593188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical burden of digital vasculopathy in limited and diffuse cutaneous systemic sclerosis.
    Nihtyanova SI; Brough GM; Black CM; Denton CP
    Ann Rheum Dis; 2008 Jan; 67(1):120-3. PubMed ID: 17660220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bosentan as a rescue therapy in scleroderma refractory digital ulcers.
    Chamaillard M; Heliot-Hosten I; Constans J; Taïeb A
    Arch Dermatol; 2007 Jan; 143(1):125-6. PubMed ID: 17224564
    [No Abstract]   [Full Text] [Related]  

  • 6. Successful treatment with bosentan for refractory digital ulcers in a patient with systemic lupus erythematosus.
    Nagai Y; Shimizu A; Ishikawa O
    J Dermatol; 2008 Jul; 35(7):447-51. PubMed ID: 18705833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Arteriographic evaluation of vascular changes of the extremities in patients with systemic sclerosis.
    Hasegawa M; Nagai Y; Tamura A; Ishikawa O
    Br J Dermatol; 2006 Dec; 155(6):1159-64. PubMed ID: 17107383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bosentan for digital ulcers in patients with systemic sclerosis: a prospective 3-year followup study.
    Tsifetaki N; Botzoris V; Alamanos Y; Argyriou E; Zioga A; Drosos AA
    J Rheumatol; 2009 Jul; 36(7):1550-2. PubMed ID: 19567637
    [No Abstract]   [Full Text] [Related]  

  • 9. [Digital ulcers in systemic sclerosis : A retrospective heath service study analysing treatment with bosentan and other vasoactive therapies].
    Riemekasten G; Beissert S; Distler JH; Kreuter A; Müller-Ladner U
    Z Rheumatol; 2017 Apr; 76(3):228-237. PubMed ID: 27535277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Bosentan for treatment of active digital ulcers in patients with systemic sclerosis].
    Launay D; Diot E; Pasquier E; Mouthon L; Boullanger N; Fain O; Jego P; Carpentier P; Hatron PY; Hachulla E
    Presse Med; 2006 Apr; 35(4 Pt 1):587-92. PubMed ID: 16614599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Digital ulcers in a cohort of 333 scleroderma patients].
    Tiso F; Favaro M; Ciprian L; Cardarelli S; Rizzo M; Tonello M; Ruffatti A; Cozzi F
    Reumatismo; 2007; 59(3):215-20. PubMed ID: 17898881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bosentan treatment of digital ulcers related to systemic sclerosis: results from the RAPIDS-2 randomised, double-blind, placebo-controlled trial.
    Matucci-Cerinic M; Denton CP; Furst DE; Mayes MD; Hsu VM; Carpentier P; Wigley FM; Black CM; Fessler BJ; Merkel PA; Pope JE; Sweiss NJ; Doyle MK; Hellmich B; Medsger TA; Morganti A; Kramer F; Korn JH; Seibold JR
    Ann Rheum Dis; 2011 Jan; 70(1):32-8. PubMed ID: 20805294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of digital ulcers in systemtic sclerosis with endothelin-1 receptor antagonist (bosentan)].
    Riccardi MT; Chialà A; Lannone F; Grattagliano V; Covelli M; Lapadula G
    Reumatismo; 2007; 59(2):135-9. PubMed ID: 17603693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bosentan in systemic sclerosis.
    Heresi GA; Minai OA
    Drugs Today (Barc); 2008 Jun; 44(6):415-28. PubMed ID: 18596996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bosentan in clinical practice for treating digital and other ischemic ulcers in Spanish patients with systemic sclerosis: IBER-DU cohort study.
    Roman Ivorra JA; Simeon CP; Alegre Sancho JJ; Egurbide MV; Castillo MJ; Lloria X; Fonollosa V
    J Rheumatol; 2011 Aug; 38(8):1631-5. PubMed ID: 21632679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Digital ulcers: overt vascular disease in systemic sclerosis.
    Steen V; Denton CP; Pope JE; Matucci-Cerinic M
    Rheumatology (Oxford); 2009 Jun; 48 Suppl 3():iii19-24. PubMed ID: 19487218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resolution of severe digital ulceration during a course of Bosentan therapy.
    Snyder MJ; Jacobs MR; Grau RG; Wilkes DS; Knox KS
    Ann Intern Med; 2005 May; 142(9):802-3. PubMed ID: 15867420
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of bosentan on nondigital ulcers in patients with systemic sclerosis.
    Taniguchi T; Asano Y; Hatano M; Tamaki Z; Tomita M; Kawashima T; Miyazaki M; Sumida H; Akamata K; Takahashi T; Ichimura Y; Toyama T; Sugita M; Noda S; Yao A; Kinugawa K; Sato S
    Br J Dermatol; 2012 Feb; 166(2):417-21. PubMed ID: 21848685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Digital ulcers in systemic sclerosis: use of endotheline antagonists].
    Mota J; Castellano A; Santiago F; Carvalho P; Madeira AS; Pereira De Moura JM; Nascimento Costa JM
    Acta Med Port; 2011; 24(5):837-42. PubMed ID: 22525638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic lupus erythematosus, complicated with refractory skin ulcers, treated successfully with bosentan.
    Suzuki E; Kyozuka H; Nishida T; Kanno T; Ohira H
    Mod Rheumatol; 2009; 19(4):447-51. PubMed ID: 19504167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.